King's College London

Research portal

Polysaccharide Multilayer Nanoencapsulation of Insulin-Producing beta-Cells Grown as Pseudoislets for Potential Cellular Delivery of Insulin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numberN/A
Pages (from-to)610 - 616
Number of pages7
Issue number3
Published8 Mar 2010


  • bm901152k

    bm901152k.pdf, 1.49 MB, application/pdf

    Uploaded date:11 Nov 2015

    Version:Final published version

    Licence:CC BY-ND

King's Authors


This paper describes the use of a layer-by-layer nanocoating technique for the encapsulation Of insulin-producing pancreatic beta-cell spheroids (pseudoislets) within chitosan/alginate multilayers. We used pseudoislets self-organized from a population of the insulinoma cell line MIN6, derived from a transgenic mouse expressing the large T-antigen of SV40 in pancreatic beta-cells, its an experimental model for the study of cell nanoencapsulation. The maintenance of spheroid morphology and retention of cell viability and metabolic functionality was demonstrated postencapsulation. By depositing an additional protein-repelling phosphorylcholine-modified chondroitin-4-sulfate layer, the coatings were found to shield effectively access of large molecules of the immune systems to the antigen-presenting cell surfaces. Transmission electron microscopy analysis of the encapsulated pseudoislets revealed that the coating did not damage the cell structure. In addition, nanoencapsulation permits the cells to respond to changes in extracellular glucose and Other insulin secretagogues by releasing insulin with I profile similar to that of nonencapsulated cells. These results suggest that this nanofilm encapsulation technique has the characteristics required for the efficient transplantation Of Cellular engineered beta-cells as a cell replacement therapy for type I diabetes. This encapsulation method is general in scope and has implications for use in a Variety of Cellular therapeutics employing engineered tissues from cells generated in vitro from various sources, including those using genetic and cellular engineering techniques.

Download statistics

No data available

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454